Skip to content
Use caution Drug recall · FDA · Published May 29, 2015

Apotex Recalls Enalapril/HCTZ Tablets Due to Uniformity Issues

Apotex recalls 10/25 mg Enalapril maleate and hydrochlorothiazide tablets due to failed content uniformity. Check your lot number KP4529.

🇺🇸 FDA recall #D-1215-2015DrugApotex ›
Take action

Contact the company

Recalling firmApotex Inc.150 Signet Drive · Toronto, Canada
✎ GovInfoNow plain-language explainer

Apotex Inc. is recalling a specific lot of Enalapril maleate and hydrochlorothiazide tablets USP (10/25 mg) because the product may not meet blend uniformity specifications. This means the active ingredients might not be evenly distributed throughout the bottle, potentially affecting how much medication you receive in each pill. The recall affects 4,584 bottles distributed nationwide, including Hawaii and Puerto Rico. Read more at govinfonow.com/recall/44607-apotex-inc-recalls-enalapril-maleate-and-hydrochlorothiazide-tablets-usp-10.

Source Summary by GovInfoNow · govinfonow.com/recall/44607-apotex-inc-recalls-enalapril-maleate-and-hydrochlorothiazide-tablets-usp-10 · Updated October 12, 2026 · FDA enforcement record: FDA #D-1215-2015

Cite this page

“Apotex Recalls Enalapril/HCTZ Tablets Due to Uniformity Issues.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44607-apotex-inc-recalls-enalapril-maleate-and-hydrochlorothiazide-tablets-usp-10. Based on FDA recall #D-1215-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1215-2015%22&limit=1).

Apotex Inc. recalled Enalapril/HCTZ Tablets USP, 10/25 mg, manufactured for Apotex Inc., due to failed content uniformity specifications, according to the FDA. The agency announced the Class II recall on May 29, 2015.

How to tell if you have it

  • Brand: Apotex
  • Product: Enalapril/HCTZ Tablets
  • Strength/Size: 10/25 mg, 100-count bottle
  • NDC: 60505-0209-1
  • Lot #: KP4529
  • Expiration: 10/2015

The hazard

The product may not meet the limit for blend uniformity specification, according to the FDA. The recall is classified as a Class II recall.

Context

GovInfoNow's records show Apotex Inc. has 19 other recalls on record since 2020-05-27. Other recent recalls of similar products include Apotex Recalls Paroxetine 37.5mg Due to Dissolution Failure (2026-09-23) and Meclizine 12.5mg Tablets Recall: Failed Tablet Specifications (2026-03-16).

How to tell if you have this one

Look for a 100-count bottle of Enalapril maleate and hydrochlorothiazide tablets USP, 10/25 mg. Check the label for NDC 60505-0209-1 and Lot # KP4529 with an expiration date of 10/2015.

  • Brand
    Apotex
  • Category
    Drug
FDA recall event · 4 products

All 4 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide, Hawaii and Puerto Rico
Recall numberProduct, codes & lotsQuantity
D-1212-2015Losartan potassium tablets USP, 25 mg, 90- count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India NDC 60505-3160-9; Lot #: KP4726, Exp date 9/201545,708 bottles
D-1213-2015Losartan potassium tablets USP, 100 mg, 90-count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India NDC 60505-3162-9; Lot #: KT3819, Exp 11/2015; Lot #: KT3821, Exp 11/201523,178 bottles
D-1214-2015Losartan potassium tablets USP, 50 mg, 90-count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India NDC 60505-3161-9; Lot #: KN1449, Exp 06/201523,076 bottles
D-1215-2015Enalapril maleate and hydrochlorothiazide tablets USP, 10/25 mg, 100-count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India, NDC 60505-0209-1; Lot #: KP4529, Exp 10/20154,584 bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Verify if your bottle matches NDC 60505-0209-1 and Lot # KP4529 with an expiration date of 10/2015.

  2. Contact Your Pharmacist

    If you have the recalled lot, contact your pharmacist or healthcare provider for instructions on replacement or disposal.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide, Hawaii and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 21 months after the firm started it.

1. Firm started the recall: May 29, 201512. FDA classified it Class II: Jul 7, 201523. Published in FDA’s Enforcement Report: Jul 15, 201534. FDA terminated the recall: Mar 3, 2017420152017
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC number for the recalled item?

The National Drug Code (NDC) is 60505-0209-1.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1215-2015 (May 29, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1215-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA